Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy
Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Source Type: news
More News: Grants | Health Management | Muscular Dystrophy | Pharmaceuticals | Reflex Sympathetic Dystrophy